CAI Meng-yue, HAO Mei-ling, LI Chun-hui. EXPRESSION AND CORRELATIONS OF OCT4 AND TGF-Β SIGNALING PATHWAY RELATED FACTORS IN GASTRIC CANCER[J]. Journal of Chengde Medical University, 2017, 34(3): 185-187.
[1] 邹文斌,李兆申.中国胃癌发病率及死亡率研究进展[J].中国实用内科杂志,2014,34(4):408-415. [2] Guseva D, Rizvanov AA, Salafutdinov II, et al.Over-expression of Oct4 and Sox2 transcription factors enhances differentiation of human umbilical cord blood cells in vivo[J]. Biochem Biophys Res Commun, 2014,451(4):503-509. [3] Lin H, Sun LH, Han W, et al.Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway[J]. Mol Med Rep, 2014,10(3):1335-1342. [4] 袁方均,周文波,邹灿,等.肝癌细胞系中Oct4与Wnt/β-catenin和TGF-β信号通路的相互影响[J].肿瘤防治研究, 2011,38(1):21-24. [5] Lamouille S, Xu J, Derynck R.Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014,15(3):178-196. [6] Lamouille S, Xu J, Derynck R.Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014,15(3):178-196. [7] Yi EY, Park SY, Jung SY, et al.Mitochondrial dysfunction induces EMT through the TGF-β/Smad/Snail signaling pathway in Hep3B hepatocellular carcinoma cells[J]. Int J Oncol, 2015,47(5):1845-1853. [8] Mallini P, Lennard T, Kirby J, et al.Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance[J]. Cancer Treat Rev, 2014,40(3):341-348.